Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 29, 2015Liver InternationalOpen Access

Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma

View Full Paper
Ask AI
Bookmark
Share

Authors

HCHamza ChettouhInsermMLMarie LequoyInsermLFLætitia FartouxSt Thomas' Hospital

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Chettouh et al. (2015) studied this question.

synapsesocial.com/papers/6a6bd72579eb7ca170247688https://doi.org/10.1111/liv.12903
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Adiponectin Antagonizes the Oncogenic Actions of Leptin in Hepatocellular Carcinogenesis2010 · 181 citations
  2. 2Suppressor of cytokine signalling (SOCS) proteins as guardians of inflammatory responses critical for regulating insulin sensitivity2014 · 101 citations
  3. 3The Role of Pre-Existing Diabetes Mellitus on Hepatocellular Carcinoma Occurrence and Prognosis: A Meta-Analysis of Prospective Cohort Studies2011 · 135 citations
  4. 4Insulin-Like Growth Factor-1 Receptor Inhibition Induces a Resistance Mechanism via the Epidermal Growth Factor Receptor/HER3/AKT Signaling Pathway: Rational Basis for Cotargeting Insulin-Like Growth Factor-1 Receptor and Epidermal Growth Factor Receptor in Hepatocellular Carcinoma2009 · 153 citations
  5. 5Metabolic Syndrome and Risk of Cancer2012 · 1,224 citations